Peter Penson on one way to cut the NHS drugs budget
In recent months, the media has reported numerous cases of patients campaigning to be given expensive anti-cancer drugs such as Herceptin by the NHS despite a lack of NICE approval. Difficult decisions must be made about how money should be spent and where economies can be made.
You need to be an HSJ subscriber to read more
Subscribe to read the full article
With an HSJ subscription you’ll get access to:
- Expert Briefing newsletters, covering nine topics and regions
- Weekly Catch Up – a summary of the week’s most important stories
- Unlimited access to hsj.co.uk
- The HSJ app
Enquire about multi-user access